Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
As noted in the GLP-1 agonist comparison table, in addition to FDA approval for T2DM alone, three of the currently available GLP-1s have been approved for the treatment of cardiovascular disease in the setting of type 2 diabetes
Parekh TM, Raji M, Lin YL, Tan A, Kuo YF, Goodwin JS
Efficacy and safety of danuglipron (PF-06882961) in adults with obesity: A randomized, placebo-controlled, dose-ranging phase 2b study
8 weeks 5 vials Covers a 4-week 300 mcg phase plus a 4-week 500 mcg phase
Access Personalized GLP-1 Care Through PlexusDx PlexusDx offers seven prescription GLP-1 protocols to all 50 states no membership, no insurance required, async intake or live consult
US$ 21.99
US$ 21.05
US$ 28.39
US$ 20.57
US$ 26.58
US$ 27.87
US$ 24.05
US$ 21.16
US$ 26.96
